China Investing 101, Series and Guide
- (this doc) Series China Investing 101, Series and Guide
- China Investing By Sector
- Political, Economics docs China Politics, Demographics and Economy Series
- Part of Series Invest Guide and Series
- International Investing Strategy
- See Series - Guide to Geo-Economic-Politics
- Military GeoPolitics Guide and Series
- China Investing 101 and Top Companies
- ===TOC=== How China Inc Works
China Investing 101 and Top Companies
Problem of Banning and Delisting Trump, CHL
China Regulators screw DIDI and 40+ pending IPOs on NYSE, etc.
Heavy Debt burdens
Shorting due to Bad Financials - Muddy Waters
Top Companies BPR
Alibaba Group Holding Ltd. JD.com, Inc. Sponsored ADR Class A
Tencent Holdings Ltd. Meituan Class B NetEase, Inc Baidu
Kweichow Moutai Co., Ltd.
NIO Inc. Sponsored ADR Class A
Wuxi Biologics (Cayman) Inc.
China Construction Bank Corporation Class H Industrial and Commercial Bank of China Limited Class H China Merchants Bank Co., Ltd. Class H Bank of China Limited Class H
Ping An Insurance (Group) Company of China, Ltd. Class H
Contemporary Amperex Technology Co., Ltd. Class A Xiaomi Corp. Class B4.22%
China Investing BPR
===TOC=== How China Inc Works
Oligarchs and Billionaires
- China: Industries and Titans that Seized the day
- Self Made Wealthy : China Billionaires Mostly Deserve to be Rich
China Rich from Tech - hurt by US sanctions
Most of China's new billionaires come from the tech industry. But rising tensions between China and the US over Huawei, TikTok and WeChat have also pushed down valuations of Chinese tech stocks.
Zhong Shanshan "lone wolf" - Asia's richest on Water/Vaccine
His net worth $77.8bn, making him the world's 11th richest person according to the Bloomberg Billionaires Index.
Mr Zhong's career has spanned journalism, mushroom farming and healthcare.
Mr Zhong took vaccine-maker Beijing Wantai Biological public in April 2020 listing its shares on the Chinese stock market. Beijing Wantai Biological's shares are up more than 2,000% by Dec end, 2020 and is among those developing a Covid-19 vaccine.
Then in July he took Nongfu Spring the bottled water company, public - listing it in Hong Kong. Since then Nongfu Spring has become one of Hong Kong's hottest listings and its shares have jumped 155% since their debut by Dec end, 2020
Jack Ma - hurt by criticizing China Banking "Regulators"
Jack Ma has seen his wealth drop from a high of $61.7bn in October down to $51.2bn as his Alibaba empire faces increased scrutiny from Chinese regulators. Alibaba is being investigated over claims of monopolistic behaviour while its affiliate Ant Group had its bumper stock market listing blocked in November.
The Ant Group shake-up - Told to stick to payments only not